{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:55:09Z","timestamp":1768035309941,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.healun.2016.09.009","type":"journal-article","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T20:00:28Z","timestamp":1475956828000},"page":"427-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Use of sirolimus in pediatric heart transplant patients: A multi-institutional study from the Pediatric Heart Transplant Study Group"],"prefix":"10.1016","volume":"36","author":[{"given":"Joseph W.","family":"Rossano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elfriede","family":"Pahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Naftel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Pruitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Lupton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Chinnock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Mahle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2016.09.009_bib1","first-page":"252","article-title":"Cyclosporine in cardiac transplantation","volume":"27","author":"Devineni","year":"1984","journal-title":"Can J Surg"},{"key":"10.1016\/j.healun.2016.09.009_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/01.CIR.71.3.487","article-title":"Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone","volume":"71","author":"Greenberg","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.09.009_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine-associated chronic nephropathy","volume":"311","author":"Myers","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.09.009_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/11535990-000000000-00000","article-title":"Strategies to prevent cellular rejection in pediatric heart transplant recipients","volume":"12","author":"Denfield","year":"2010","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.healun.2016.09.009_bib5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1747-0803.2011.00601.x","article-title":"Pediatric coronary allograft vasculopathy\u2014a review of pathogenesis and risk factors","volume":"7","author":"Schumacher","year":"2012","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.healun.2016.09.009_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-3046.2012.01644.x","article-title":"Current status of immunosuppressive agents for solid organ transplantation in children","volume":"16","author":"Coelho","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00007890-199502150-00014","article-title":"Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506","volume":"59","author":"Cao","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.09.009_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.RES.76.3.412","article-title":"Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells","volume":"76","author":"Marx","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2016.09.009_bib9","first-page":"2833","article-title":"Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts","volume":"23","author":"Akselband","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2016.09.009_bib10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2249.1994.tb06058.x","article-title":"Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells","volume":"96","author":"Kim","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.healun.2016.09.009_bib11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1399-3046.2012.01697.x","article-title":"Conversion to sirolimus in pediatric renal transplant patients: a single-center experience","volume":"16","author":"Monteverde","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib12","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1399-3046.2011.01566.x","article-title":"Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients","volume":"15","author":"Chinnock","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.healun.2004.11.005","article-title":"Sirolimus immunosuppression in pediatric heart transplant recipients: a single-center experience","volume":"24","author":"Lobach","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib14","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1399-3046.2011.01560.x","article-title":"Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients","volume":"15","author":"Basso","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1399-3046.2010.01363.x","article-title":"The use of sirolimus as a rescue therapy in pediatric intestinal transplant recipients","volume":"14","author":"Andres","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1399-3046.2011.01550.x","article-title":"Renal function in children with heart transplantation after switching to CNI-free immunosuppression with everolimus","volume":"15","author":"Behnke-Hall","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","article-title":"Use of rapamycin slows progression of cardiac transplantation vasculopathy","volume":"108","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.09.009_bib18","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.transproceed.2005.02.090","article-title":"Preservation of renal function after heart transplantation: initial single-center experience with sirolimus","volume":"37","author":"De Meester","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2016.09.009_bib19","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.transproceed.2010.12.055","article-title":"Everolimus plus dosage reduction of cyclosporine in cardiac transplant recipients with chronic kidney disease: a two-year follow-up study","volume":"43","author":"Fuchs","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2016.09.009_bib20","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial","volume":"10","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.09.009_bib21","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/TP.0b013e3181fd01b7","article-title":"Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial","volume":"90","author":"Gullestad","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.09.009_bib22","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.healun.2005.02.018","article-title":"Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation","volume":"24","author":"Hunt","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib23","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.transproceed.2012.09.045","article-title":"Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients","volume":"44","author":"Kaplinsky","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2016.09.009_bib24","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.healun.2005.08.015","article-title":"Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity","volume":"24","author":"Kushwaha","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.healun.2007.01.017","article-title":"Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months\u2019 follow-up","volume":"26","author":"Rothenburger","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib26","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.transproceed.2010.12.062","article-title":"Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years\u2019 follow-up from the University Hospital Munster","volume":"43","author":"Stypmann","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2016.09.009_bib27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.healun.2010.01.005","article-title":"Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation","volume":"29","author":"Gude","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.transproceed.2010.01.022","article-title":"Recovery of renal function in heart transplantation patients after conversion from a calcineurin inhibitor-based therapy to sirolimus","volume":"42","author":"Ayub-Ferreira","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2016.09.009_bib29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/TP.0b013e3181963371","article-title":"Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure","volume":"87","author":"Groetzner","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.09.009_bib30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCULATIONAHA.111.040360","article-title":"Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation","volume":"125","author":"Topilsky","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.09.009_bib31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.healun.2006.01.004","article-title":"Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients","volume":"25","author":"Balfour","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1399-3046.2010.01306.x","article-title":"Indications, tolerance and complications of a sirolimus and calcineurin inhibitor immunosuppression regimen: intermediate experience in pediatric heart transplantation recipients","volume":"14","author":"Matthews","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib33","first-page":"II69","article-title":"Outcome of cardiac transplantation in children. Survival in a contemporary multi-institutional experience. Pediatric Heart Transplant Study","volume":"94","author":"Shaddy","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2016.09.009_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.healun.2004.03.021","article-title":"The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study","volume":"24","author":"Pahl","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.healun.2010.09.005","article-title":"Infection and malignancy after pediatric heart transplantation: the role of induction therapy","volume":"30","author":"Gajarski","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.healun.2012.05.016","article-title":"Has late rejection decreased in pediatric heart transplantation in the current era? A multi-institutional study","volume":"31","author":"Ameduri","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1399-3046.2011.01564.x","article-title":"Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study","volume":"15","author":"Feingold","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.healun.2015.10.025","article-title":"Early initiation of mTOR inhibitors in children with heart transplantation: a propensity-based registry analysis","volume":"35","author":"Castleberry","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib39","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib40","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1600-6143.2012.04131.x","article-title":"Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency","volume":"12","author":"Zuckermann","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib41","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.09.009_bib42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.healun.2011.12.010","article-title":"Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate","volume":"31","author":"Arora","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.09.009_bib43","doi-asserted-by":"crossref","first-page":"A12452","DOI":"10.1161\/circ.132.suppl_3.12452","article-title":"Clinical practice patterns are relatively uniform between pediatric heart transplant centers: a survey based assessment (abstract)","volume":"132","author":"Castleberry","year":"2015","journal-title":"Circulation"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816303370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816303370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:33:01Z","timestamp":1760949181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249816303370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1053249816303370"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2016.09.009","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of sirolimus in pediatric heart transplant patients: A multi-institutional study from the Pediatric Heart Transplant Study Group","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2016.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}